{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:06:10Z","timestamp":1792501570551,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["505"],"award-info":[{"award-number":["505"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.biopha.2018.04.109","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T13:35:06Z","timestamp":1524663306000},"page":"965-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone"],"prefix":"10.1016","volume":"103","author":[{"given":"Narjes","family":"Hendouei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Farnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Mohseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Shadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Barzegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Davood","family":"Hoseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid Yazdani","family":"Charati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Shaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.04.109_bib0005","series-title":"Phenotype of Schizophrenia: A Review and Formulation","author":"Tamminga","year":"2005"},{"issue":"7","key":"10.1016\/j.biopha.2018.04.109_bib0010","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1089\/ars.2010.3603","article-title":"Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view","volume":"15","author":"Yao","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.biopha.2018.04.109_bib0015","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: an integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2018.04.109_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.2272","article-title":"Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study)","volume":"28","author":"Miljevi\u0107","year":"2013","journal-title":"Hum. Psychopharmacol.: Clin. Exp."},{"issue":"6","key":"10.1016\/j.biopha.2018.04.109_bib0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3956(98)00028-4","article-title":"Effects of haloperidol on antioxidant defense system enzymes in schizophrenia","volume":"32","author":"Yao","year":"1998","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.biopha.2018.04.109_bib0030","first-page":"237","article-title":"Oxidative stress in schizophrenia-focusing on the main markers","volume":"23","author":"Ciobica","year":"2011","journal-title":"Psychiatria Danubina"},{"issue":"11","key":"10.1016\/j.biopha.2018.04.109_bib0035","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/pcn.12333","article-title":"First\u2010episode psychosis is associated with oxidative stress: effects of short\u2010term antipsychotic treatment","volume":"69","author":"Sarandol","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2018.04.109_bib0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0197-0186(00)00108-X","article-title":"Protein thiol oxidation by haloperidol results in inhibition of mitochondrial complex I in brain regions: comparison with atypical antipsychotics","volume":"38","author":"Balijepalli","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2018.04.109_bib0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.biopha.2016.02.047","article-title":"Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models","volume":"81","author":"Brinholi","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2018.04.109_bib0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2018.04.109_bib0055","first-page":"39","article-title":"The spectroscopic determination of aqueous sulfite using Ellman\u2019s reagent","volume":"8","author":"Sadegh","year":"2003","journal-title":"MURJ"},{"issue":"3","key":"10.1016\/j.biopha.2018.04.109_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cbf.290020310","article-title":"Adenine nucleotides in thrombocytes of birds","volume":"2","author":"Wachowicz","year":"1984","journal-title":"Cell Biochem. Funct."},{"issue":"3","key":"10.1016\/j.biopha.2018.04.109_bib0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0891-5849(97)00104-4","article-title":"Protein carbonyl measurement by a sensitive ELISA method","volume":"23","author":"Buss","year":"1997","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.04.109_bib0070","first-page":"167","article-title":"Activity of superoxide dismutase (SOD) enzyme in the excretory-secretory products of Fasciola hepatica and F. gigantica parasites","volume":"8","author":"Farahnak","year":"2013","journal-title":"Iranian J. Parasitol."},{"issue":"4","key":"10.1016\/j.biopha.2018.04.109_bib0075","article-title":"Total phenolic content and ferric reducing antioxidant power of the leaves and fruits of Garcinia atrovirdis and Cynometra cauliflora","volume":"20","author":"Rabeta","year":"2013","journal-title":"Int. Food Res. J."},{"issue":"2","key":"10.1016\/j.biopha.2018.04.109_bib0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.biopha.2018.04.109_bib0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1440-1819.2009.02015.x","article-title":"Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile","volume":"63","author":"Pazvantoglu","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2018.04.109_bib0090","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.pbb.2004.05.018","article-title":"Haloperidol-and clozapine-induced oxidative stress in the rat brain","volume":"78","author":"Polydoro","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.biopha.2018.04.109_bib0095","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2298\/ABS1404559D","article-title":"Direct correlation between the scores of PANSS\/AIMS scales and some oxidative stress markers in treated schizophrenic patients","volume":"66","author":"Dobrin","year":"2014","journal-title":"Arch. Biol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2018.04.109_bib0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000444488","article-title":"Oxidative stress and DNA damage in untreated first-episode psychosis in adolescents","volume":"73","author":"\u015eim\u015fek","year":"2016","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.biopha.2018.04.109_bib0105","first-page":"157","article-title":"Oxidative stress as marker of positive symptoms in schizophrenia","volume":"9","author":"Pavlovi\u0107","year":"2002","journal-title":"Facta Univ."},{"issue":"4","key":"10.1016\/j.biopha.2018.04.109_bib0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000077368","article-title":"Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics","volume":"49","author":"Dakhale","year":"2004","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.biopha.2018.04.109_bib0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","article-title":"Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"37","author":"Parikh","year":"2003","journal-title":"J. Psychiatric Res."},{"issue":"2","key":"10.1016\/j.biopha.2018.04.109_bib0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.schres.2016.07.010","article-title":"Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia","volume":"176","author":"Sadowska-Bartosz","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.biopha.2018.04.109_bib0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2015.02.028","article-title":"Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum","volume":"591","author":"Andreazza","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2018.04.109_bib0130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.pnpbp.2005.11.009","article-title":"Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine","volume":"30","author":"Gama","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2018.04.109_bib0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2004.09.032","article-title":"Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain","volume":"372","author":"Reinke","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2018.04.109_bib0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","article-title":"Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia","volume":"156","author":"Kapur","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.biopha.2018.04.109_bib0145","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/hup.1076","article-title":"Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects","volume":"24","author":"Souza","year":"2009","journal-title":"Hum. Psychopharmacol.: Clin. Exp."},{"issue":"2","key":"10.1016\/j.biopha.2018.04.109_bib0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pnpbp.2009.11.024","article-title":"Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients","volume":"34","author":"Miljevic","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.biopha.2018.04.109_bib0155","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s11064-013-1050-z","article-title":"The effects of ziprasidone, clozapine and haloperidol on lipid peroxidation in human plasma (in vitro): comparison","volume":"38","author":"Dietrich-Muszalska","year":"2013","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.biopha.2018.04.109_bib0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/jnp.17.2.227","article-title":"Oxidative stress during treatment with first-and second-generation antipsychotics","volume":"17","author":"Kropp","year":"2005","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2018.04.109_bib0165","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.neuropharm.2011.12.014","article-title":"Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia","volume":"62","author":"Zhang","year":"2012","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2018.04.109_bib0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neulet.2010.05.088","article-title":"Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics","volume":"479","author":"Padurariu","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.biopha.2018.04.109_bib0175","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00005053-199211000-00007","article-title":"The positive and negative syndrome scale and the brief psychiatric rating scale: reliability, comparability, and predictive validity","volume":"180","author":"Bell","year":"1992","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.biopha.2018.04.109_bib0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.psychres.2016.11.021","article-title":"Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics","volume":"247","author":"Bas","year":"2017","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.biopha.2018.04.109_bib0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-9964(02)00407-3","article-title":"Reduced plasma antioxidants in first-episode patients with schizophrenia","volume":"62","author":"Reddy","year":"2003","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.04.109_bib0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/24750573.2017.1293243","article-title":"Oxidative metabolism may be associated with negative symptoms in schizophrenia","volume":"27","author":"Gunes","year":"2017","journal-title":"Psychiatry Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2018.04.109_bib0195","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00213-005-0117-1","article-title":"Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia","volume":"182","author":"Dakhale","year":"2005","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2018.04.109_bib0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09540260600581993","article-title":"Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia","volume":"18","author":"Mahadik","year":"2006","journal-title":"Int. Rev. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2018.04.109_bib0205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cccn.2003.11.003","article-title":"Antioxidant potential of vitamins A, E and C in modulating oxidative stress in rat brain","volume":"340","author":"Zaidi","year":"2004","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.biopha.2018.04.109_bib0210","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1089\/ars.2012.4720","article-title":"Severe life stress and oxidative stress in the brain: from animal models to human pathology","volume":"18","author":"Schiavone","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"11","key":"10.1016\/j.biopha.2018.04.109_bib0215","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.2174\/1381612821666150105143358","article-title":"Impact of early life stress on the pathogenesis of mental disorders: relation to brain oxidative stress","volume":"21","author":"Schiavone","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.biopha.2018.04.109_bib0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1179\/1476830514Y.0000000139","article-title":"Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol","volume":"19","author":"Bo\u0161kovi\u0107","year":"2016","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.biopha.2018.04.109_bib0225","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9616593","article-title":"Antipsychotic treatment reduces indices of oxidative stress in first-episode psychosis patients","volume":"2016","author":"Kriisa","year":"2016","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218302397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218302397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T01:32:58Z","timestamp":1720661578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218302397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":45,"alternative-id":["S0753332218302397"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.04.109","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.04.109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}